Poster published on April 10th at the 2021 American Association for Cancer Research (AACR) Annual Meeting shows the GP2 final 5 year immune response data from the Phase IIb clinical trial, concluding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback